International Medicine and Health Guidance News ›› 2025, Vol. 31 ›› Issue (14): 2313-2316.DOI: 10.3760/cma.j.cn441417-20241213-14006
• New Medical Advances • Previous Articles Next Articles
Application of injection therapy in androgenic alopecia
Cao Yinghan, Gao Yu
Department of Dermatology and Venereology, Binzhou Medical University Hospital, Binzhou 256600, China
Received:
2024-12-13
Online:
2025-07-01
Published:
2025-08-04
Contact:
Gao Yu, Email: binyigaoyu@126.com
Supported by:
Shandong Provincial Graduate Education Quality Teaching Resources Project in 2022 (SDYAL2022185)
注射治疗在雄激素性脱发中的应用进展
曹影菡 高昱
滨州医学院附属医院皮肤病与性病科,滨州 256600
通讯作者:
高昱,Email:binyigaoyu@126.com
基金资助:
2022年山东省研究生优质教育教学资源项目(SDYAL2022185)
Cao Yinghan, Gao Yu.
Application of injection therapy in androgenic alopecia [J]. International Medicine and Health Guidance News, 2025, 31(14): 2313-2316.
曹影菡 高昱.
注射治疗在雄激素性脱发中的应用进展 [J]. 国际医药卫生导报, 2025, 31(14): 2313-2316.
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.imhgn.com/EN/10.3760/cma.j.cn441417-20241213-14006
[1]周城,范卫新,方红,等.中国雄激素性秃发诊疗指南(2023)[J].临床皮肤科杂志,2024,53(12):752-758. DOI: 10.16761/j.cnki.1000-4963.2024.12.015. [2]Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community-based study in six cities[J]. Br J Dermatol, 2010, 162(4): 843-847. DOI: 10.1111/j.1365-2133.2010.09640.x. [3]孙彩红,赖永贤,汪青良,等. 342例雄激素性脱发患者生活质量与心理状况分析[J].中国中西医结合皮肤性病学杂志,2023,22(3):259-261. DOI:10.3969/j.issn.1672-0709.2023.03.011. [4]Heilmann S, Kiefer AK, Fricker N, et al.Androgenetic alopecia: identification of four genetic risk loci and evidence for the contribution of WNT signaling to its etiology[J]. J Invest Dermatol, 2013, 133(6):1489-1496. DOI: 10.1038/jid.2013.43. [5]王敏,王霞.热激蛋白27联合miR-1介导雄激素受体上调导致雄激素性脱发发病[J].中南大学学报(医学版),2022,47(1):72-78. DOI: 10.11817/j.issn.1672-7347.2022.210131. [6]Upadhyay DK, Sharma A, Sarma GS, et al. Mechanism of androgenic alopecia: addressing speculations through empirical evidences[J]. Dermatol Ther, 2019, 32(6): e13120. DOI:10.1111/dth.13120. [7]王超凡,范卫新.女性型秃发的发病特点及临床诊疗更新[J].临床皮肤科杂志,2024,53(12):759-763. DOI:10.16761/j.cnki.1000-4963.2024.12.016. [8]Tang X, Cao C, Liang Y, et al. Adipose-derived stem cell exosomes antagonize the inhibitory effect of dihydrotestosterone on hair follicle growth by activating Wnt/β-Catenin pathway[J]. Stem Cells Int, 2023: 5548112. DOI: 10.1155/2023/5548112. [9]程飚,朱絮,杨域,等.浓缩血小板在毛发再生中的临床应用专家共识(2022版)[J].中国美容整形外科杂志,2023,34(1): 6-13. [10]Calciolari E, Dourou M, Akcali A, et al. Differences between first- and second-generation autologous platelet concentrates[J]. Periodontol 2000, 2025, 97(1):52-73.DOI: 10.1111/prd.12550. [11]Sharma A, Chouhan K, Bhatia S, et al. Platelet-rich plasma in androgenetic alopecia[J]. Indian Dermatol Online J, 2021, 12 Suppl 1: S31-S40. DOI: 10.4103/idoj.idoj_328_21. [12]Pakhomova EE, Smirnova IO. Comparative evaluation of the clinical efficacy of PRP-therapy, minoxidil, and their combination with immunohistochemical study of the dynamics of cell proliferation in the treatment of men with androgenetic alopecia[J]. Int J Mol Sci, 2020, 21(18): 6516. DOI: 10.3390/ijms21186516. [13]Li M, Qu K, Lei Q, et al. Effectiveness of platelet-rich plasma in the treatment of androgenic alopecia: a meta-analysis[J]. Aesthetic Plast Surg, 2024, 48(5): 977-984. DOI: 10.1007/S00266-023-03603-9. [14]Pereira VBS, Lago CAP, Almeida RAC, et al. Biological and cellular properties of Advanced Platelet-Rich Fibrin (A-PRF) compared to other platelet concentrates: systematic review and meta-analysis[J]. Int J Mol Sci, 2023, 25(1): 482. DOI: 10.3390/ijms25010482. [15]Shashank B, Bhushan M. Injectable Platelet-Rich Fibrin (PRF): the newest biomaterial and its use in various dermatological conditions in our practice: a case series [J]. J Cosmet Dermatol, 2021, 20(5): 1421-1426. DOI: 10.1111/jocd.13742. [16]Karimi K, Rockwell H. The benefits of platelet-rich fibrin[J]. Facial Plast Surg Clin North Am, 2019, 27(3): 331-340. DOI: 10.1016/j.fsc.2019.03.005. [17]Cervino G, Oteri G, D'Amico C, et al. Molecular features and tissue engineering techniques applied to regenerative surgery: an overview of recent data[J]. Minerva Dent Oral Sci, 2021, 70(3): 119-127. DOI: 10.23736/S2724-6329.21.04517-9. [18]Pohching T,周双白,吴巍,等.自体浓缩生长因子治疗男性雄激素源性脱发的临床应用20例[J].组织工程与重建外科杂志,2019,15(3):159-162,184. DOI:10.3969/j.issn.1673-0364.2019.03.008. [19]Tan PC, Zhang PQ, Xie Y, et al. Autologous concentrated growth factors combined with topical minoxidil for the treatment of male androgenetic alopecia: a randomized controlled clinical trial[J]. Facial Plast Surg Aesthet Med, 2021, 23(4): 255-262. DOI: 10.1089/fpsam.2020.0288. [20]徐林刚,陈龙金,李彦锋,等.自体浓缩生长因子联合A型肉毒毒素治疗男性雄激素性脱发临床疗效[J].中国医疗美容, 2022, 12(7): 51-56. DOI:10.19593/j.issn.2095-0721.2022.07.013. [21]程飚.富血小板血浆依然是整形美容外科治疗的希望[J].中国美容医学, 2020, 29(10): 2-7. DOI:10.15909/j.cnki.cn61-1347/r.003966. [22]Cole JP, Cole MA, Insalaco C, et al.Alopecia and platelet-derived therapies[J]. Stem Cell Investig, 2017, 4:88. DOI: 10.21037/sci.2017.11.01. [23]Guan Q, Guo ZH, Dai DM, et al. Platelet lysate promotes hair growth: in vitro and in vivo mechanism and randomized, controlled trial[J]. Biomed Pharmacother, 2023, 161: 114517. DOI: 10.1016/j.biopha.2023.114517. [24]Shirshakova M, Morozova E, Sokolova D, et al. The effectiveness of botulinum toxin type A (BTX-A) in the treatment of facial skin oily seborrhea, enlarged pores, and symptom complex of post-acne [J]. Int J Dermatol, 2021, 60(10): 1232-1241. DOI: 10.1111/ijd.15574. [25]Jung BH., Song SH, Yoon SJ, et al. The effect of botulinum toxin on hair follicle cell regeneration under continuous stress conditions: a pilot animal study[J]. Neurotox Res, 2022, 40(1): 103-110. DOI: 10.1007/s12640-021-00453-8. [26]Zhou Y, Yu S, Zhao J, et al. Effectiveness and safety of botulinum toxin type a in the treatment of androgenetic alopecia[J]. Biomed Res Int, 2020: 1501893. DOI: 10.1155/2020/1501893. [27]Hussein RS, Dayel SB, Abahussein O. Botulinum toxin a for hair loss treatment: a systematic review of efficacy, safety, and future directions[J]. JPRAS Open, 2023, 38: 296-304. DOI:10.1016/j.jpra.2023.09.006. [28]吴艳,吴琳,于波.肉毒毒素注射在皮肤美容中应用的专家共识(2023版)[J].中国美容医学, 2023, 32(11): 1-9. DOI:10.15909/j.cnki.cn61-1347/r.006008. [29]Shon U, Kim MH, Lee DY, et al. The effect of intradermal botulinum toxin on androgenetic alopecia and its possible mechanism[J]. J Am Acad Dermatol, 2020, 83(6): 1838-1839. DOI: 10.1016/j.jaad.2020.04.082. [30]周亚光,于水,赵纪敏,等. A型肉毒毒素治疗雄激素性脱发的临床研究[J].中国美容医学, 2021, 30(5): 101-103. DOI: 10.15909/j.cnki.cn61-1347/r.004413. [31]Elmaadawi IH, Mohamed BM, Ibrahim ZAS, et al. Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia[J]. J Dermatolog Treat, 2018, 29(5): 431-440. DOI: 10.1080/09546634.2016.1227419. [32]Gentile P, Scioli MG, Bielli A, et al. Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss[J]. Stem Cell Investig, 2017, 4: 58. DOI: 10.21037/sci.2017.06.04. [33]Fukuoka H, Narita K, Suga H. Hair regeneration therapy: application of adipose-derived stem cells [J]. Curr Stem Cell Res Ther, 2017, 12(7): 531-534. DOI: 10.2174/1574888X12666170522114307. [34]Bak DH, Choi MJ, Kim SR, et al. Human umbilical cord blood mesenchymal stem cells engineered to overexpress growth factors accelerate outcomes in hair growth[J]. Korean J Physiol Pharmacol, 2018, 22(5): 555-566. DOI: 10.4196/kjpp.2018.22.5.555. [35]温立霞,吴为民.自体脂肪基质血管成分的临床研究进展[J].医学综述, 2020, 26(18): 3553-3558. DOI: 10.3969/j.issn.1006-2084.2020.18.004. [36]Kim SJ, Kim MJ, Lee YJ, et al. Innovative method of alopecia treatment by autologous adipose-derived SVF[J]. Stem Cell Res Ther, 2021, 12(1): 486. DOI: 10.1186/S13287-021-02557-6. [37]El-Khalawany M, Rageh MA, Elnokrashy I, et al. Efficacy of autologous stromal vascular fraction injection in the treatment of androgenic alopecia[J]. Arch Dermatol Res, 2023, 315(5): 1269-1276. DOI: 10.1007/S00403-022-02501-5. [38]Butt G, Hussain I, Ahmad FJ, et al. Stromal vascular fraction-enriched platelet-rich plasma therapy reverses the effects of androgenetic alopecia[J]. J Cosmet Dermatol, 2020, 19(5): 1078-1085. DOI: 10.1111/jocd.13149. |
[1] |
Zhang Guibin, Deng Yajun, Chen Xinqing, Cao Meng, Xu Yan.
Evaluation of the effect of percutaneous corner vertebroplasty in the treatment of osteoporotic vertebral compression fractures [J]. International Medicine and Health Guidance News, 2025, 31(9): 1410-1415. |
[2] |
Zhang Bo, Zhang Bin.
Efficacy of modified PVP in the treatment of senile patients with mid-thoracic OVCF complicated with degenerative spinal disease [J]. International Medicine and Health Guidance News, 2025, 31(9): 1415-1420. |
[3] |
Yang Yuetai, Jia Benzhi.
Correlation analysis between bone cement/vertebral body volume ratio and adjacent vertebral compression fractures after percutaneous vertebroplasty [J]. International Medicine and Health Guidance News, 2025, 31(9): 1421-1425. |
[4] |
Chen Xiaoyan, Zhou Guojun, Shi Kui, Li Ziqiang, Sun Feifei.
Risk factors analysis of recurrent fracture in elderly patients with osteoporotic thoracolumbar compression fracture after PVP [J]. International Medicine and Health Guidance News, 2025, 31(9): 1426-1429. |
[5] |
Ren Fei, Zhang Haiping, Gao Shansong.
Construction and validation of a risk model for adjacent segment disease after lumbar fusion surgery based on preoperative spinal - pelvic parameters and intervertebral disc characteristics [J]. International Medicine and Health Guidance News, 2025, 31(9): 1430-1435. |
[6] |
Yang Li, Jin Xingshan.
Clinical effect of Qidong Yixin Granules combined with core muscle group training on patients with spinal cord injury [J]. International Medicine and Health Guidance News, 2025, 31(9): 1435-1439. |
[7] |
Ma Hang, Zhang Bing.
Levels of serum S100A12 and peripheral blood RDW and Mono% and their clinical significance in patients with spinal tuberculosis and their clinical significance [J]. International Medicine and Health Guidance News, 2025, 31(9): 1440-1444. |
[8] |
Liu Qing, Ren Wenjuan, Zhong Hongping.
Influencing factors of intravenous immunoglobulin resistance and coronary artery damage in children with Kawasaki disease [J]. International Medicine and Health Guidance News, 2025, 31(9): 1451-1456. |
[9] |
Jiang Hong, Xue Dongqing.
Effect of infliximab combined with tacrolimus on children with Kawasaki disease resistant to initial immunoglobulin therapy and its impact on immune function [J]. International Medicine and Health Guidance News, 2025, 31(9): 1456-1460. |
[10] |
Zhi Danlin, Huo Chaokui Lu, Jianmei, Xia Ruiqing, Cheng Hao, Cao Danmin.
Advances in intraocular lens refractive power calculation for cataract surgery following radial keratotomy [J]. International Medicine and Health Guidance News, 2025, 31(9): 1461-1465. |
[11] |
Zhao Zhou, Liu Weipeng, Li Zongrui, Wang Ruizhi, Hu Baoguang.
Research status of hypertensive rat model [J]. International Medicine and Health Guidance News, 2025, 31(9): 1465-1470. |
[12] |
Zan Xingchun.
Research progress and prospects of Tongdu Tiaoshen acupuncture in the treatment of post-stroke dysphagia [J]. International Medicine and Health Guidance News, 2025, 31(9): 1470-1474. |
[13] |
Sang Yang, Han Xinpeng, Yan Yuling, Zhang Shaoyi.
Study on the mechanism of CD147 in regulating airway remodeling in asthma rats based on Akt-FoxO3-NF-κB signaling axis [J]. International Medicine and Health Guidance News, 2025, 31(9): 1482-1488. |
[14] |
Wu Yali, Fu Xiaoping, Ding Dawei, Xu Ning'an, Zhou Yuanyuan.
Risk factors related to children attention deficit hyperactivity disorder and construction of prediction model [J]. International Medicine and Health Guidance News, 2025, 31(9): 1489-1494. |
[15] |
Wang Qingyuan, Fang Yuanlong, Wang Zhiqin, Huang Rong, Tian Song, Yuan Like, Ge Wuping, Zhu Xiaochun, Xiao Shangjie, Zhou Jialiang.
Analysis of diagnosis and treatment of secondary intestinal stenosis after conservative treatment of neonatal necrotizing enterocolitis [J]. International Medicine and Health Guidance News, 2025, 31(9): 1495-1498. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||